Sphera Funds Management’s Freeline Therapeutics Holdings FRLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-16,445
Closed -$105K – 125
2023
Q4
$105K Buy
+16,445
New +$88.1K 0.02% 97

Sphera Funds Management's FRLN Position: Q1 2024 in Review

Sphera Funds Management sold out of Freeline Therapeutics Holdings (FRLN) in Q1 2024, closing a stake of 16,445 shares — an estimated $105K sold.

Sphera Funds Management first reported a position in FRLN in Q4 2023 and held it in 1 quarter. The position peaked at $105K in Q4 2023. 0 funds tracked by Wall St. Rank hold FRLN as of Q1 2024.

  • Sphera Funds Management reported no remaining Freeline Therapeutics Holdings position as of Q1 2024 after selling out during the quarter.
  • Sphera Funds Management sold 16,445 Freeline Therapeutics Holdings shares in Q1 2024, an estimated $105K.
  • Sphera Funds Management first reported a position in Freeline Therapeutics Holdings in Q4 2023 and held it in 1 quarter.
  • Sphera Funds Management's Freeline Therapeutics Holdings position peaked at $105K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings as of Q1 2024.

Based on Sphera Funds Management's 13F filing for Q1 2024, filed 15 May 2024.